Search

everythinglearnresearchcommunity

for

Search:↓

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

New treatments for PCOS focus on managing symptoms and improving fertility.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The research found that measuring androgens in urine can give extra information about body metabolism and is linked to androgen levels in the blood, especially in young girls.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

COVID-19 may harm male fertility and damage the reproductive system.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Xeno-free three-dimensional stem cell masses are safe and effective for improving blood flow and tissue repair in limb ischemia.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

A certain mutation in the fetal alpha 5-reductase gene is linked to a higher risk of late miscarriage.

Chitosan-decorated finasteride nanosystems improve skin retention and could be a better treatment for hair loss.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

Synthetic hormone treatment reduces melanin and hair growth in rats.

Insulinomas and adrenocortical tumors are common in older ferrets, diagnosed with blood tests and ultrasounds, and treated with medications or surgery.